Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient

被引：50
|
作者：
Weir, A
WansbroughJones, M
机构：
[1] UNIV LONDON ST GEORGES HOSP,SCH MED,DEPT MED,LONDON SW17 0RE,ENGLAND
[2] UNIV LONDON ST GEORGES HOSP,SCH MED,DEPT CELLULAR & MOL SCI,LONDON SW17 0RE,ENGLAND
来源：
AIDS | 1997年 / 11卷 / 15期
关键词：
D O I：
10.1097/00002030-199715000-00022
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1895 / 1896
页数：2
相关论文
共 50 条
  • [31] Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy
    Depairon, M
    Chessex, S
    Sudre, P
    Rodondi, N
    Doser, N
    Chave, JP
    Riesen, W
    Nicod, P
    Darioli, R
    Telenti, A
    Mooser, V
    [J]. AIDS, 2001, 15 (03) : 329 - 334
  • [32] Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor
    Murphy, M
    Armstrong, D
    Sepkowitz, KA
    Ahkami, RN
    Myskowski, PL
    [J]. AIDS, 1997, 11 (02) : 261 - 262
  • [33] Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy
    Dios, PD
    Ocampo, A
    Miralles, C
    Otero, I
    Iglesias, I
    Rayo, N
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1999, 87 (04): : 437 - 441
  • [34] Weight gain associated with protease inhibitor therapy in HIV-infected patients
    Stricker, RB
    Goldberg, B
    [J]. RESEARCH IN VIROLOGY, 1998, 149 (02): : 123 - 126
  • [35] Kaposi's sarcoma in an immunocompetent patient following corticosteroid therapy
    Anton, Enrique
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (03) : 226 - 226
  • [36] Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
    V Martinez
    E Caumes
    L Gambotti
    H Ittah
    J-P Morini
    J Deleuze
    I Gorin
    C Katlama
    F Bricaire
    N Dupin
    [J]. British Journal of Cancer, 2006, 94 : 1000 - 1006
  • [37] Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
    Martinez, V
    Caumes, E
    Gambotti, L
    Ittah, H
    Morini, JP
    Deleuze, J
    Gorin, I
    Katlama, C
    Bricaire, F
    Dupin, N
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (07) : 1000 - 1006
  • [38] Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda
    Asiimwe, F. M.
    Moore, D. M.
    Were, W.
    Nakityo, R.
    Campbell, J.
    Barasa, A.
    Mermin, J.
    Kaharuza, F.
    [J]. HIV MEDICINE, 2012, 13 (03) : 166 - 171
  • [39] A Rare Gastrointestinal Presentation in an HIV-Infected Patient Colonic Kaposi's Sarcoma Causing Massive Bleeding and Lymphatic Kaposi Sarcoma Causing Refractory Chylous Anasarca
    Abdelfatah, Mohamed M.
    Tuttle, Bryan
    [J]. GASTROENTEROLOGY, 2017, 152 (06) : E7 - E9
  • [40] Hepatitis C virus is not a cofactor for Kaposi's sarcoma development in HIV-infected patients
    Schepers, K.
    Van Vooren, J. P.
    Simonart, T.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (08) : 994 - 995
12345